Obesity Diagnosis: The Truth Beyond the Scale

Obesity diagnosis involves more than reading a number on a scale. Weight and body mass index (BMI) can be useful starting points, but neither tells us where fat is stored, how much muscle a person has, or whether excess body fat is affecting their health.

WEIGHT MANAGEMENT

Sarina Helton, FNP, MSN, CAE_OM

10/10/20266 min read

Understanding body fat, waist size, metabolic health, and South Asian risk

This is especially important for people of South Asian ancestry, who may develop type 2 diabetes and other cardiometabolic conditions at lower BMI and waist measurements than many other populations.

At Optima Vida Healthcare, we look at the whole picture: body size, fat distribution, medical history, symptoms, physical function, vital signs, laboratory results, medications, and personal goals.

What Is Obesity?

Obesity is a chronic, complex disease involving excess or abnormally distributed body fat that can impair health. It is influenced by far more than willpower. Genetics, biology, medications, sleep, stress, health conditions, food access, environment, and life circumstances can all play a role.

Obesity may increase the risk of or contribute to conditions such as:

Type 2 diabetes
High blood pressure
Abnormal cholesterol or triglyceride levels
Metabolic dysfunction-associated steatotic liver disease, formerly called fatty liver disease
Obstructive sleep apnea
Osteoarthritis and impaired mobility
Cardiovascular disease
Certain reproductive and hormonal conditions

However, two people with the same weight or BMI can have very different body composition, fat distribution, symptoms, and health risks.

BMI: Useful, but Incomplete

BMI compares weight with height:

BMI = weight in kilograms ÷ height in meters squared

Standard adult BMI categories in the United States are:

BMI. Standard category

Below 18.5. Underweight

18.5–24.9 Healthy weight

25.0–29.9 Pre-obesity

30.0–34.9 Class 1 obesity

35.0–39.9 Class 2 obesity

40.0 or higher Class 3 obesity

BMI is inexpensive and useful for screening, but it does not directly measure body fat. It also cannot distinguish fat mass from muscle or show where fat is stored. A muscular person may have a higher BMI without excess body fat, while another person may have a BMI below 30 but carry excess abdominal or visceral fat.

One commonly confused point: a BMI of 27 or higher plus a weight-related condition is often used as an eligibility threshold for anti-obesity medication. It is not the standard BMI definition of obesity.

Why South Asian Risk May Be Missed

People with ancestry from India, Pakistan, Bangladesh, Sri Lanka, Nepal, Bhutan, or the Maldives are not all metabolically alike. Still, population research shows that South Asian adults often develop insulin resistance, type 2 diabetes, and cardiovascular risk at lower BMI levels than White populations.

Several factors may contribute, including a tendency toward:

More abdominal and visceral fat at a given BMI
Higher body-fat percentage at a given BMI
Lower average lean mass
Earlier development of insulin resistance and type 2 diabetes

For this reason, some clinical guidelines apply lower BMI thresholds to South Asian and certain other ethnic groups. One current approach lowers the standard BMI categories by approximately 2.5 kg/m²:

Lower-threshold category used by some guidelines = BMI

Pre-Obesity =23.0–27.4

Obesity = 27.5 or higher

In the United States, a BMI of 23 or higher in Asian American adults is also an important threshold for considering diabetes screening when other guideline criteria are met. This is a screening threshold—not proof that everyone with a BMI of 23 or higher has obesity or diabetes.

The central message is simple: a BMI that appears to be in the standard “healthy” or “overweight” range does not automatically mean cardiometabolic risk is low.

A Better Obesity Assessment

1. BMI and Weight History

BMI remains a useful starting point when interpreted in context. We also consider weight trajectory, previous highest weight, major weight changes, prior treatment, medications, pregnancy history, and factors that may have contributed to weight gain or loss.

2. Waist Circumference and Fat Distribution

Waist circumference provides information that BMI cannot: whether excess fat is concentrated around the abdomen. Visceral fat—the fat surrounding internal organs—is strongly associated with cardiometabolic risk.

Commonly used thresholds indicating increased risk in South Asian adults are:

Women: 80 cm or more (about 31.5 inches)
Men: 90 cm or more (about 35.5 inches)

These are risk-screening thresholds, not a diagnosis by themselves. Waist-to-height ratio may also be helpful; a simple general target is to keep waist circumference below half of height, although interpretation should still be individualized.

3. Body Composition When It Will Change Care

Body-composition tools can estimate fat mass and lean mass. Options include bioelectrical impedance, DEXA, and imaging obtained for other medical reasons. Each method has limitations, and results from consumer scales can vary substantially with hydration and other factors.

Body-fat percentage should not be interpreted using a single universal cutoff. Age, sex, ethnicity, testing method, and clinical context matter. The most useful question is not simply, “Is this percentage high?” but, “Does this result add meaningful information or change the care plan?”

4. Metabolic and Medical Evaluation

Testing should be based on personal risk, symptoms, health history, examination, and medications. An evaluation may include:

Blood pressure
A1C or fasting glucose
Lipid panel, including triglycerides and HDL cholesterol
Liver enzymes when indicated
Kidney function when indicated
Screening for sleep apnea, liver disease, cardiovascular risk, or other complications

Fasting insulin, C-reactive protein, thyroid testing, and reproductive hormone panels are not required for every obesity evaluation. They may be appropriate when specific symptoms or clinical findings suggest a reason to order them.

5. Symptoms, Function, and Health Effects

A modern assessment asks not only whether excess fat is present, but whether it is affecting organs, tissues, mobility, or daily life.

In 2025, an international expert commission proposed distinguishing:

Preclinical obesity: excess body fat is present, but there is no current obesity-related organ dysfunction or substantial limitation in daily activities.
Clinical obesity: excess body fat is causing organ or tissue dysfunction, symptoms, or meaningful limitations in daily activities.

This newer framework reinforces an important point: health status and function matter. It is an emerging model and does not replace every current U.S. diagnostic, prescribing, or insurance rule.

6. Personal, Family, and Cultural Context

A meaningful evaluation also considers:

Family history of diabetes, cardiovascular disease, and other metabolic conditions
Eating patterns and culturally important foods
Physical activity, strength, sleep, and stress
Food access, work schedule, caregiving demands, and cost barriers
Medications that may affect weight or appetite
Previous weight-management experiences
The patient’s preferences and goals

Culturally responsive care does not mean assuming that every South Asian person eats or lives the same way. It means asking respectful questions and creating a plan that fits the individual.

Can Someone Have Obesity and Still Have Normal Lab Results?

Yes. A person can have excess body fat without current abnormalities in glucose, blood pressure, liver enzymes, or cholesterol. That does not guarantee future disease, nor does it mean treatment is unnecessary. Risk varies substantially from person to person and can change over time.

The opposite is also true: someone with a BMI below the obesity range can have abdominal adiposity, prediabetes, fatty liver disease, or other metabolic risk.

This is why the goal is not to label someone as “healthy” or “unhealthy” based on appearance, weight, or one laboratory panel. The goal is to identify current health effects, estimate future risk, and decide together whether monitoring or treatment would be beneficial.

Three Practical Ways to Monitor Metabolic Health

Measure More Than Weight

If it is useful for your care, track waist circumference periodically using the same method each time. Daily or compulsive measurement is unnecessary; trends are more meaningful than small fluctuations.

Protect and Build Muscle

Resistance training, adequate protein, and appropriate nutrition can help preserve or increase lean mass. Muscle supports physical function and glucose metabolism, especially during weight loss.

Build Meals Around Foods That Fit Your Culture and Goals

A sustainable eating pattern may include:

Adequate protein from foods such as fish, poultry, eggs, dairy, tofu, lentils, beans, or other preferred sources
Fiber-rich vegetables, fruit, legumes, and whole grains
Portions of refined grains and sweets that support your individual glucose and weight goals
Traditional foods adapted when helpful—not automatically eliminated

Brown rice is not mandatory, and white rice does not need to be labeled a “bad” food. Portion size, meal balance, frequency, total dietary pattern, and personal metabolic response all matter.

Obesity Care Should Reflect the Whole Person

BMI is not useless, but it should not stand alone. A thoughtful obesity evaluation combines BMI with waist size or another measure of adiposity, medical and weight history, metabolic risk, current health effects, physical function, and the patient’s priorities.

For South Asian patients, using appropriate risk thresholds can help identify concerns earlier—before a “normal-looking” BMI creates false reassurance.

At Optima Vida Healthcare, our goal is not to chase a number or force every patient into the same plan. It is to understand what is affecting your health and develop a realistic, evidence-based approach that fits your life.

This article is for general educational purposes only and does not provide a diagnosis or replace individualized medical advice. Diagnostic standards, medication eligibility, and insurance requirements may differ. Seek care from a qualified healthcare professional for personal recommendations.

References

Centers for Disease Control and Prevention. About Body Mass Index (BMI).
National Institute for Health and Care Excellence. Identifying and assessing overweight, obesity and central adiposity. 2025.
Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13(3):221–262.
Hsu WC, Araneta MRG, Kanaya AM, Chiang JL, Fujimoto W. BMI cut points to identify at-risk Asian Americans for type 2 diabetes screening. Diabetes Care. 2015;38(1):150–158.
American Diabetes Association. Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults. Diabetes, Obesity, and Cardiometabolic Care. 2026;1(4):536–548.

Ready to Start Your Weight Management Journey?

GLP-1 medications can be powerful tools, but the right medication, dose, and rate of dose escalation can be different for each person.

At Optima Vida Healthcare, weight management is individualized based on your health history, previous treatments, response to medication, side effects, goals, and long-term needs.

Treatment may include GLP-1 or other weight-management medications when medically appropriate, along with ongoing monitoring and support.

Start Your Weight Management Evaluation →

Or Visit www.ovhmed.com for more information.